Caligan Partners as of June 30, 2023
Portfolio Holdings for Caligan Partners
Caligan Partners holds 13 positions in its portfolio as reported in the June 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Liquidia Corp Com New (LQDA) | 40.8 | $73M | 9.2M | 7.85 | |
| Anika Therapeutics (ANIK) | 10.5 | $19M | 720k | 25.98 | |
| Exelixis (EXEL) | 9.8 | $17M | 911k | 19.11 | |
| D Fluidigm Corp Del (LAB) | 9.2 | $16M | 8.5M | 1.93 | |
| Intercept Pharmaceuticals In | 8.0 | $14M | 1.3M | 11.06 | |
| Intercept Pharmaceuticals Put Put Option | 7.5 | $13M | 1.2M | 11.06 | |
| Evolus (EOLS) | 7.2 | $13M | 1.8M | 7.27 | |
| Verona Pharma Sponsored Ads (VRNA) | 2.2 | $3.9M | 183k | 21.14 | |
| Adma Biologics (ADMA) | 1.8 | $3.1M | 848k | 3.69 | |
| Eyepoint Pharmaceuticals Com New (EYPT) | 1.5 | $2.7M | 310k | 8.70 | |
| Alimera Sciences Com New (ALIM) | 0.8 | $1.4M | 479k | 2.92 | |
| Recro Pharma (SCTL) | 0.7 | $1.2M | 1.1M | 1.10 | |
| Agios Pharmaceuticals (AGIO) | 0.1 | $137k | 4.8k | 28.32 |
